Xu Liu

5PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 19, 2019
Letter: are sorafenib-related adverse events associated with prolonged survival?

Jian-Xu Li, Xu Liu, Shao-Tong Tang

|Aug 07, 2019
Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma.

Wen-Feng Gong, Jian-Hong Zhong, Zhan Lu

|Jul 18, 2019
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma.

Xu Liu, Rong-Rong Jia, Chun-Yan Zhang

|Jun 13, 2019
Is synchronous hepatectomy and splenectomy superior to hepatectomy alone for selected patients with hepatocellular carcinoma and clinically significant portal hypertension?

Xian-Long Xie, Xu Liu, Jie Ou

|Feb 26, 2019
Is monocyte-to-lymphocyte ratio the best systematic inflammatory biomarker for the prognosis of gastrointestinal stromal tumors?

Dun-Chang Mo, Xu Liu, Yu-Jie Lv

Pageof 1

Frequent Collaborators

1 joint publications

Jian-Hong Zhong

1 joint publications

Le-Qun Li